Presenting IDRIA B, the unparalleled breakthrough for injectable platelet-rich fibrin (iPRF)
iPRF contains IDRIA B 30ml tube and accessories for blood draw. IDRIA B offers to create injectable platelet-rich fibrin (iPRF), a fully autologous, blood-derived biomaterial having three-dimensional fibrin meshwork. Like that of a PRF clot, while retaining the fluid nature, similar to platelet-rich plasma (PRP). Along with platelets and its growth factors, injectable PRF has predominantly mononuclear cells along with its growth factors and fibrinogen. Preparation of injectable PRF is simple and requires minimal instrumentation and materials, making it a cost-effective product. Clinical application has been effective in androgenetic alopecia treatment, periorbital rejuvenation, temporary filler material and as an agent to promote wound healing with favourable results.
IDRIA B ensures the creation of a specialized component that concentrates and harvests fibrinogen and platelets, resulting in an optimal compound for volumetric and regenerative effects.
By processing 30 ml of blood, physicians can obtain different ml of PRP with high concentrations of regenerative cells and proteins in a single 4-minute spin (1650 rgf).
IDRIA B does not contain ACD-a and gel-separator, which allows physicians to choose the volume of product desired to treat the area with a volumetric effect.